Home Business & Finance Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker
Business & Finance

Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker

Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker
Key Points

Jun 16th, 2026 Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker Biocon founder Kiran Mazumdar Shaw says she is confident that the company's investment and capacity expansion in Insulin will make the company the top hub for the drug in the next five years. She speaks in an exclusive conversation with Bloomberg's Haslinda Amin.

Jun 16th, 2026 Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker Biocon founder Kiran Mazumdar Shaw says she is confident that the company's investment and capacity expansion in Insulin will make the company the top hub for the drug in the next five years. She speaks in an exclusive conversation with Bloomberg's Haslinda Amin.
Biocon's Mazumdar Shaw (ORG) Biocon (ORG) Kiran Mazumdar Shaw (PERSON) Insulin (ORG) Bloomberg (PERSON) Haslinda Amin (PERSON)
Originally published by Bloomberg Markets Read original →